الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hospira, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 40 mg in 1 ml - dopamine hcl injection is indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output. dopamine is contraindicated in patients with pheochromocytoma. risk summary there are no human data with dopamine use in pregnant women. there are risks to the mother and fetus from hypotension associated with shock, which can be fatal if left untreated (see clinical considerations ). in animal reproduction studies, adverse developmental outcomes were observed with intravenous dopamine hcl administration in pregnant rats during organogenesis at doses, on a mcg/m2 basis, of one‑third the human starting dose of 2 mcg/kg/minute (90 mcg/m2 /minute). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies carry some risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2‑4% and 15‑20%,

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hospira, inc. - dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x) - dopamine hydrochloride 0.8 mg in 1 ml - dopamine hydrochloride in dextrose injection is indicated to improve hemodynamic status in patients in distributive shock, or shock due to reduced cardiac output. dopamine is contraindicated in patients with pheochromocytoma. risk summary there are no human data with dopamine use in pregnant women. there are risks to the mother and fetus from hypotension associated with shock, which can be fatal if left untreated (see clinical considerations ). in animal reproduction studies, adverse developmental outcomes were observed with intravenous dopamine hcl administration in pregnant rats during organogenesis at dosages, on a mcg/m2 basis, of one-third the human starting dosage of 2 mcg/kg/minute (90 mcg/m2 /minute). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies carry some risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the background risk of major birth defects and miscarriage in clinically recognized pregna

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - glucagon hydrochloride (unii: 1h87nvf4db) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagen is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. glucagen is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagen is contraindicated in patients with: risk summary available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. multiple small studies have demonstrated a lack of transfer of pancreatic glucagon across the human placental barrier during early gestation. in rat and rabbit reproduction studies, no embryofetal toxicity was observed with glucagon administered by injection during the period of organogenesis at doses representing up to 100 and 200 times the human dose, respectively, based on body surface area (mg/m2 ) (see data). the estimated background

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

general injectables and vaccines, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. 1.2 hypotension associated with septic shock adrenalin is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. none. 8.1 pregnancy risk summary prolonged experience with epinephrine use in pregnant women over several decades, based on published literature, do not identify a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.  however, there are risks to the mother and fetus associated with epinephrine use during labor or delivery (see clinical considerations ).  in animal reproduction studies, epinephrine administered by the subcutaneous route to pregnant rabbits, mice, and hamsters, during the period of organogenesis, resulted in adverse developmen

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

tya pharmaceuticals - glucagon (unii: 76la80ig2g) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - for the treatment of hypoglycemia: glucagon is indicated as a treatment for severe hypoglycemia. because patients with type 1 diabetes may have less of an increase in blood glucose levels compared with a stable type 2 patient, supplementary carbohydrate should be given as soon as possible, especially to a pediatric patient. for use as a diagnostic aid: glucagon is indicated as a diagnostic aid in the radiologic examination of the stomach, duodenum, small bowel, and colon when diminished intestinal motility would be advantageous. glucagon is as effective for this examination as are the anticholinergic drugs. however, the addition of the anticholinergic agent may result in increased side effects. glucagon is contraindicated in patients with known hypersensitivity to it or in patients with known pheochromocytoma. glucagon for injection (rdna origin) become familiar with the following instructions before an emergency arises. do not use this kit after date stamped on the bottle label. if you have questions concern

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

physicians total care, inc. - glucagon (unii: 76la80ig2g) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagon is indicated as a treatment for severe hypoglycemia. because patients with type 1 diabetes may have less of an increase in blood glucose levels compared with a stable type 2 patient, supplementary carbohydrate should be given as soon as possible, especially to a pediatric patient. glucagon is indicated as a diagnostic aid in the radiologic examination of the stomach, duodenum, small bowel, and colon when diminished intestinal motility would be advantageous. glucagon is as effective for this examination as are the anticholinergic drugs. however, the addition of the anticholinergic agent may result in increased side effects. glucagon is contraindicated in patients with known hypersensitivity to it or in patients with known pheochromocytoma. glucagon for injection (rdna origin) become familiar with the following instructions before an emergency arises. do not use this kit after date stamped on the bottle label. if you have questions concerning the use of this product, consult a doctor, nurse or ph

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

novo nordisk - glucagon hydrochloride (unii: 1h87nvf4db) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagen is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. glucagen is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagen is contraindicated in patients with: risk summary available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. multiple small studies have demonstrated a lack of transfer of pancreatic glucagon across the human placental barrier during early gestation. in rat and rabbit reproduction studies, no embryofetal toxicity was observed with glucagon administered by injection during the period of organogenesis at doses representing up to 100 and 200 times the human dose, respectively, based on body surface area (mg/m2 ) (see data). the estimated background

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

fresenius kabi usa, llc - glucagon hydrochloride (unii: 1h87nvf4db) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagon for injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. glucagon for injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagon for injection is contraindicated in patients with: - pheochromocytoma [see warnings and precautions (5.1)] - insulinoma [see warnings and precautions (5.2)] because of the risk of hypoglycemia - known hypersensitivity to glucagon or any of the excipients in glucagon for injection. allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [see warnings and precautions (5.3)] - glucagonoma [see warnings and precautions (5.8)] because of risk of hypoglycemia when used as a diagnostic aid risk summary available data from case reports and a small number of observational studies with glucagon use in pregnant women over decades of use have not

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

eli lilly and company - glucagon (unii: 76la80ig2g) (glucagon - unii:76la80ig2g) - glucagon 1 mg in 1 ml - glucagon for injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus. glucagon for injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. glucagon for injection is contraindicated in patients with: - pheochromocytoma because of the risk of substantial increase in blood pressure [see warning and precautions (5.1)] - insulinoma because of the risk of hypoglycemia [see warning and precautions (5.2)] - known hypersensitivity to glucagon or any of the excipients in glucagon for injection. allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [see warning and precautions (5.3)] - glucagonoma when used as a diagnostic aid because of the risk of hypoglycemia [see warnings and precautions (5.8)] risk summary available data from case reports and a small number of observational st

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

bpi labs, llc - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 1 mg in 1 ml - epinephrine injection usp, 1 mg/ml is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from allergic reactions to insect stings, biting insects, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. the signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritus, urticaria or angioedema, swelling of the eyelids, lips, and tongue. induction and maintenance of mydriasis during intraocular surgery. none. teratogenic effects: pregnancy category c: there are no adequate and well-controlled studies in pregnant women. epinephrine crosses the placenta. e